Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

At a special awards ceremony held in the Diabetes Centre at Sligo University Hospital, on Tuesday, Diabetes Ireland honoured ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

In the search for affordable, high-quality diabetes supplies, Border Free Health has become a trusted name. Offering essential diabetes care products like insulin pumps, blood glucose meters, test ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated India Prefilled Syringes Market size by value at USD 1.13 billion in 2023. During the forecast ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

"According to the latest study from BCC Research "Infusion Pumps and Devices: Technologies and Global Markets," the global market is expected to grow from $10.1 billion in 2024 to $14.7 billion by the ...